Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936 (Q79919418)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 March 2007

Language	Label	Description	Also known as
English	Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936	scientific article published on 10 March 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351766%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351766%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

D Raccah

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351766%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

10 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351766%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351766%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351766%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351766%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1109-10; author reply 1111

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351766%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17351766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936

1 reference

https://pubmed.ncbi.nlm.nih.gov/17351766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17351766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17351766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17351766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17351766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17351766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/17351766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17351766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17351766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79919418&oldid=2220787996"